TRENDING:

NCPE Recommends Conditional Access for Omeprazole
Stratipath And Roche Collaborate To Expand Access To Ai...
A. Menarini Diagnostics and Nucleix Form Strategic Part...
  • Home
  • Media
  • Company
Synopulse.com
  • News
  • Industry Trends
    • Pricing & Market Access
    • Earnings Report
    • Market Pulse
    • Speciality
      • Neurology
      • Orthopaedics
      • Oncology
      • Cardiometabolic
      • Pediatrics
    • Dealstreet
    • Litigation, Law & Policy
    • MedTech
  • Regulatory
    • FDA Updates
    • EMA Updates
    • Device Approvals
    • Global Compliance
  • Monthly Standout
    • Monthly Insight’s
    • GreenLight Report
  • Special Reports
    • Synopulse 360
    • Synopulse Insights
    • RWE Lens
    • White Paper
    • Case Study
  • Magazine
    • Pulse Prime
    • Pulse of the Month
  • Disease Spotlight
  • Summits
  • Podcasts

Select Page

CorroHealth Acquired Revenue Cycle Management Business from Navient

Sep 20, 2024 | Dealstreet, News

CorroHealth has finalized its acquisition of the healthcare revenue cycle management (RCM) business from Navient’s Xtend Healthcare, significantly expanding its capabilities in revenue cycle management consultancy and technology. This strategic move enhances CorroHealth’s RCM offerings, introducing multichannel patient engagement capabilities that were previously missing from its suite of services. By adding these capabilities, CorroHealth strengthens its position as a leader in providing comprehensive, end-to-end clinical and financial solutions to healthcare providers.

The acquisition brings over 925 Xtend employees into the CorroHealth team, further boosting the company’s ability to deliver a more robust and well-rounded set of services. Pat Leonard, CEO of CorroHealth, highlighted the importance of this expansion, noting that the additional talent and expertise will offer clients greater financial security and allow them to concentrate more on delivering high-quality healthcare. The new services introduced through this acquisition aim to reduce the operational burden on healthcare organizations, improving their financial health and patient experience.

Xtend Healthcare President Mike Morris echoed this enthusiasm, stating that joining CorroHealth opens up a broader range of automation tools and capabilities for Xtend’s existing customers. The acquisition positions CorroHealth as one of the largest and most capable revenue cycle management providers, offering enhanced technological solutions that cater to both clinical and financial aspects of healthcare management.

Share:

PreviousNanoVation Therapeutics Partners with Novo Nordisk to Develop Genetic Medicines for Cardiometabolic and Rare Diseases
NextOncoC4 merged with AcroImmune
Synopulse Weekly

Synopulse Weekly: Top Deals, FDA Moves & Pricing Insights

Read Now
  • Cardiometabolic
  • Dealstreet
  • Device Approvals
  • EMA Updates
  • FDA Updates
  • Litigation, Law & Policy
  • MedTech
  • Monthly Insight's
  • Neurology
  • News
  • Oncology
  • Orthopaedics
  • Pediatrics
  • Pricing & Market Access
  • Regulatory
  • July 2025
  • June 2025
  • February 2025
  • January 2025
  • October 2024
  • September 2024

© 2025 Axowit | All Rights Reserved